Petmed Express (PETS) closed at $0.90 on November 16, 2026, down 4.5% from the previous close, on volume of 220,207 shares (30-day average 120,933).
Data as of November 16, 2026.
PetMeds Announces Second Quarter Financial Results
Globe Newswire (Tue, 10-Nov 4:05 PM ET)
Globe Newswire (Mon, 9-Nov 4:05 PM ET)
Globe Newswire (Tue, 27-Oct 4:15 PM ET)
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:05 PM ET)
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
Globe Newswire (Mon, 21-Sep 8:30 AM ET)
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
PetMeds Appoints Andrew Parry as Chief Technology Officer
Globe Newswire (Mon, 14-Sep 4:05 PM ET)
Market Chameleon (Tue, 30-Jun 6:33 AM ET)
Market Chameleon (Mon, 29-Jun 5:52 AM ET)
PetMeds Unveils Wellness-Focused Holiday Collection Aimed at Health-Conscious Pet Parents
Market Chameleon (Thu, 11-Dec 4:53 AM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of November 17, 2026, PETS stock price declined to $0.88 with 23,711 million shares trading.
PETS has a beta of 0.85, meaning it tends to be less sensitive to market movements. PETS has a correlation of 0.02 to the broad based SPY ETF.
PETS has a market cap of $19.56 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $36 million in Revenue and -$.31 earnings per share. This beat revenue expectation by $29 million and missed earnings estimates by -$.20.
In the last 3 years, PETS traded as high as $7.94 and as low as $.85.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, BSVO, IWC, BUSM.
PETS has underperformed the market in the last year with a price return of -56.0% while the SPY ETF gained +9.7%. PETS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -51.8% and -26.7%, respectively, while the SPY returned -5.8% and -3.0%, respectively.
PETS support price is $.87 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.